The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 70-73

  Kim, Min ^a   Ahn, Byung Yong ^a   Lee, Ji Seon ^a   Chung, Sung Soo ^a   Lim, Soo ^b   Park, Sang Gyu ^a   Jung, Hye Seung ^a   Lee, Hong Kyu ^a   Park, Kyong Soo ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Ginsenoside; Insulin signaling; IRS 1; Rg3

Indexed keywords

ADENYLATE KINASE; GINSAM; GINSENG EXTRACT; GINSENOSIDE RG 3; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; MYOTUBE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL LINE; GINSENOSIDES; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MUSCLE FIBERS, SKELETAL; PROTEIN KINASES; RATS; RATS, INBRED STRAINS; RNA, MESSENGER;

RATTUS;

EID: 70349093060     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.088     Document Type: Article

References (21)

1. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
2. White M.F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182 (1998) 3-11
3. Virkamaki A., Ueki K., and Kahn C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103 (1999) 931-943
4. Huang C., Thirone A.C., Huang X., and Klip A. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. J. Biol. Chem. 280 (2005) 19426-19435
5. Kubota N., Tobe K., Terauchi Y., Eto K., Yamauchi T., Suzuki R., Tsubamoto Y., Komeda K., Nakano R., Miki H., Satoh S., Sekihara H., Sciacchitano S., Lesniak M., Aizawa S., Nagai R., Kimura S., Akanuma Y., Taylor S.I., and Kadowaki T. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 (2000) 1880-1889
6. Kido Y., Burks D.J., Withers D., Bruning J.C., Kahn C.R., White M.F., and Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105 (2000) 199-205
7. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., and Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19 (1999) 4008-4018
8. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw III E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., and Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 (2001) 1728-1731
9. Gillis C.N. Panax ginseng pharmacology: a nitric oxide link?. Biochem. Pharmacol. 54 (1997) 1-8
10. Kim J.H., Hahm D.H., Yang D.C., Lee H.J., and Shim I. Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J. Pharmacol. Sci. 97 (2005) 124-131
11. Attele A.S., Zhou Y.P., Xie J.T., Wu J.A., Zhang L., Dey L., Pugh W., Rue P.A., Polonsky K.S., and Yuan C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51 (2002) 1851-1858
12. Yun S.N., Moon S.J., Ko S.K., Im B.O., and Chung S.H. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch. Pharm. Res. 27 (2004) 790-796
13. Choi K.T. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol. Sin. 29 (2008) 1109-1118
14. Lim S., Yoon J.W., Choi S.H., Cho B.J., Kim J.T., Chang H.S., Park H.S., Park K.S., Lee H.K., Kim Y.B., and Jang H.C. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism 58 (2009) 8-15
15. Hwang J.T., Lee M.S., Kim H.J., Sung M.J., Kim H.Y., Kim M.S., and Kwon D.Y. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother. Res. 23 (2009) 262-266
16. Holmes B.F., Kurth-Kraczek E.J., and Winder W.W. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 87 (1999) 1990-1995
17. Zheng D., MacLean P.S., Pohnert S.C., Knight J.B., Olson A.L., Winder W.W., and Dohm G.L. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J. Appl. Physiol. 91 (2001) 1073-1083
18. Nakagawa Y., Shimano H., Yoshikawa T., Ide T., Tamura M., Furusawa M., Yamamoto T., Inoue N., Matsuzaka T., Takahashi A., Hasty A.H., Suzuki H., Sone H., Toyoshima H., Yahagi N., and Yamada N. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat. Med. 12 (2006) 107-113
19. Friedman J.E., Ishizuka T., Shao J., Huston L., Highman T., and Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48 (1999) 1807-1814
20. Carvalho E., Jansson P.A., Nagaev I., Wenthzel A.M., and Smith U. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J. 15 (2001) 1101-1103
21. Blair A.S., Hajduch E., Litherland G.J., and Hundal H.S. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 274 (1999) 36293-36299